MEFI: MEsh FIxation in Laparoendoscopic Repair of Large M3 Inguinal Hernias

Sponsor
Swissmed Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05678465
Collaborator
Klinika Chirurgii Ogólnej, Onkologicznej i Endokrynologicznej Szpitala Zespolonego w Kielcach (Other), Oddział Chirurgii Ogólnej MCM Jonscher w Łodzi (Other), Oddział Chirurgii Ogólnej i Onkologicznej Szpitala w Wejherowie (Other), Klinika Chirurgii Ogólnej i Onkologicznej UM w Łodzi (Other), Oddział Chirurgii Ogólnej, Małoinwazyjnej i Wieku Podeszłego Miejskiego Szpitala Zespolonego w Olsztynie (Other), Oddział Chirurgii Ogólnej Regionalnego Centrum Zdrowia w Lubinie (Other), Klinika Chirurgii Ogólnej, Wojskowy Instytut Medycyny Lotniczej w Warszawie (Other), Oddział Chirurgii Ogólnej, SPOZ w Siedlcach (Other), Oddział Chirurgii Ogólnej Szpitala w Puszczykowie (Other), Oddział Chirurgii Ogólnej z Pododdziałem Urazowo-Ortopedycznym Szpitala w Szczytnie (Other)
204
1
2
24
8.5

Study Details

Study Description

Brief Summary

The goal of this Multicenter Clinical Trial is to verify the hypothesis that non-fixation of the 3-D anatomical mesh (Dextile Anatomical Mesh or 3D Max Mesh) is non-inferior in terms of recurrence compared to fixation of lightweight, macroporous meshes in laparoendoscopic repairs of large M3 inguinal hernias.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Non-fixation of the mesh
  • Procedure: Fixation of the mesh
N/A

Detailed Description

INTRODUCTION International guidelines of groin hernia treatment strongly recommends to fixate the mesh in case of large M3 medial defects during laparoendoscopic approach (TAPP / TEP). Main purpose of fixation is to decrease recurrence rate which is alarmingly high in case of those defects. Recommendation was based on analysis of large German database (Herniamed). However, deeper look into those findings shows that most of TAPP and TEP procedures were performed with the use of lightweight, flat, macroporous meshes. In 2022 multidisciplinary team consisting of hernia surgeons and scientists from universities of technology conducted an experimental study with the use of 3d groin model to confirm or deny the hypothesis that fixation is not necessary in above cases. Study was conducted with the use of all 3-D anatomical meshes available on Polish market, as well as with flat, macroporous implants. Experiment showed that large, rigid and anatomically shaped meshes are able to maintain its position in groin without need of fixation. To confirm experimental results we decided to conduct large, multicentre, clinical study to evaluate necessity of mesh fixation of large, spatial, standard polypropylene implants.

STUDY HYPOTHESIS Non-fixation of spatial, standard polypropylene meshes is non-inferior as compared to fixation of flat, polypropylene lightweight meshes during TAPP / TEP procedures.

MATERIALS AND METHODS 11 large surgery centres in Poland having proficiency in laparoendoscopic groin hernia repairs (performing at least 80 TAPP/TEP a year) were recruited for this study. Before recruiting patients a two day "bootcamp" meeting was planned. Each centre designated one surgeon responsible for conducing the trial in its hospital and sent him/her to meeting. Recurrence rate in 12-month follow-up was set as a primary endpoint. Pain sensation (assessed with VAS scale) was made a secondary endpoint. Statistical analysis was performed by experts to adjust the sample sizes. The trial was planned as non-inferiority study with test power = 80%, p-value = 0,05 and threshold for clinical significance = 8%. Percentage loss was assumed at 10%. Recurrence rate was assumed 4% based on literature. Based on those assumptions minimal sample size in both arms was calculated at 83-102. Inclusion criteria: elective groin hernia repair, age > 18 years, male and female patients can participate, M3 or M3+L1-3 (EHS classification) groin hernia confirmed during surgery, eligibility to laparoendoscopic repair, written informed consent. Exclusion criteria: age <18 years, emergency surgery (incarcerated hernia), contaminated surgical field, extremely large scrotal hernia with the need of other forms of prevention of ACS (preoperative botox injection, bowel resection etc.) First arm (control group) will consist of patients repaired with the use of flat, macroporous, lightweight mesh fixated with histoacryl glue. Second arm will consist of patients repaired with the use of anatomically shaped, large, standard, polypropylene mesh (Dextile Anatomical Mesh - MEDTRONIC or 3D Max Mesh - BD) without the use of fixation material.

As M3 hernias are difficult to diagnose before the surgery, all patients planned for laparoendscopic repairs will be asked to participate in trial. During the surgery, when the defect size is measured, patient will be fully included in the study. After dissection of preperitoneal space (and establishing crucial checkpoints), surgeon will open envelope and find out the technique he will have to perform. Patients won't be aware of the method used during surgery. Unblinding will take place at the end of the trial. Pain will be measured during the hospital stay and then 7-days, 3-months and 12-months after surgery (VAS Scale). Follow up will be performed by Medical Assistant via phone call (also blinded to the method used). If any doubts occur, patient will be asked to come to ambulatory visit.

PREDICTED OUTCOMES Based on experimental study published in Surgical Endoscopy (Zamkowski et al., 2022) and own experience, we believe that recurrence rate in both arms will be on the same level. Those outcomes will be a strong argument for amending the guidelines in terms of mesh fixation. It would show that mesh fixation is not necessary if the proper, spatial mesh is used.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
204 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients in both arms will recieve intervention. First arm (mesh + fixation) serves also as control. Patients in second arm will be operated with mesh without fixation.Patients in both arms will recieve intervention. First arm (mesh + fixation) serves also as control. Patients in second arm will be operated with mesh without fixation.
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
Double-blinded (surgeon/patient)
Primary Purpose:
Treatment
Official Title:
MEsh FIxation in Laparoendoscopic Repair of Large M3 Inguinal Hernias - Multicenter, Double-blinded, Randomized Controlled Trial.
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Feb 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: FIXATION

Lightweight macroporous mesh at least 15x10cm will be placed in preperitoneal space and fixated with use of histoacryl glue. Mesh - B Braun® Optilene Mesh® or BD® SoftMesh® Glue - Histoacryl® LapFix

Procedure: Fixation of the mesh
Glue fixation of lightweight, macroporous, polypropylene mesh.
Other Names:
  • B Braun Optilene Mesh
  • BD SoftMesh
  • Experimental: NON-FIXATION

    Standard, 3-D, anatomical mesh will be placed in preperitoneal space without the use of fixating materials. Mesh - BD® 3D Max® Mesh or Medtronic® Dextile Anatomical Mesh®

    Procedure: Non-fixation of the mesh
    3D-shaped, anatomical, standard, polypropylene mesh without fixation.
    Other Names:
  • 3D Max Mesh (BD)
  • Dextile Anatomical Mesh (Medtronic)
  • Outcome Measures

    Primary Outcome Measures

    1. Reccurence Rate [12-months]

      Reccurence in 1 year after surgery

    Other Outcome Measures

    1. Pain score [7-days, 3-months, 12-months]

      Pain sensation using Pain Visual Analog Scale (VAS)

    2. Other complications [7-days, 3-months, 12-months]

      Other surgical complications (seroma, hematoma, surgical site infections - SSI etc.)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • elective groin hernia repair,

    • M3 or M3+L1-3 (EHS classification) groin hernia confirmed during surgery

    • eligibility to laparoendoscopic repair

    • written informed consent

    Exclusion Criteria:
    • emergency surgery (incarcerated hernia)

    • contaminated surgical field

    • recurrent hernia

    • extremely large scrotal hernia with the need of other forms of prevention of Abdominal Compartment Syndrome (botox injection, preoperative progressive pneumoperitoneum - PPP, bowel resection etc.)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Swissmed Hospital Gdańsk Poland 80-280

    Sponsors and Collaborators

    • Swissmed Hospital
    • Klinika Chirurgii Ogólnej, Onkologicznej i Endokrynologicznej Szpitala Zespolonego w Kielcach
    • Oddział Chirurgii Ogólnej MCM Jonscher w Łodzi
    • Oddział Chirurgii Ogólnej i Onkologicznej Szpitala w Wejherowie
    • Klinika Chirurgii Ogólnej i Onkologicznej UM w Łodzi
    • Oddział Chirurgii Ogólnej, Małoinwazyjnej i Wieku Podeszłego Miejskiego Szpitala Zespolonego w Olsztynie
    • Oddział Chirurgii Ogólnej Regionalnego Centrum Zdrowia w Lubinie
    • Klinika Chirurgii Ogólnej, Wojskowy Instytut Medycyny Lotniczej w Warszawie
    • Oddział Chirurgii Ogólnej, SPOZ w Siedlcach
    • Oddział Chirurgii Ogólnej Szpitala w Puszczykowie
    • Oddział Chirurgii Ogólnej z Pododdziałem Urazowo-Ortopedycznym Szpitala w Szczytnie

    Investigators

    • Study Chair: Mateusz Zamkowski, MD, PhD, Swissmed Hospital
    • Study Director: Maciej Śmietański, Prof., Swissmed Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Mateusz Zamkowski, MD, PhD, Swissmed Hospital
    ClinicalTrials.gov Identifier:
    NCT05678465
    Other Study ID Numbers:
    • MEFI TRIAL
    First Posted:
    Jan 10, 2023
    Last Update Posted:
    Feb 2, 2023
    Last Verified:
    Feb 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Mateusz Zamkowski, MD, PhD, Swissmed Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 2, 2023